Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-4-27
|
pubmed:abstractText |
Twenty-two patients who underwent chemotherapy with cisplatin (CDDP) at doses > 100 mg/m2 also received antiemetic treatment comprised of the combination of ondansetron plus dexamethasone. The results obtained have shown a good activity from this combination with these high doses of CDDP, with a response of 81.8% (complete+major protection). There were also three therapeutic failures in patients with a few negative prognostic characteristics. It is our intention to use a benzodiazepine and adequate psychological support in an attempt to increase the response percentages in these kinds of patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1120-009X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
60-2
|
pubmed:dateRevised |
2009-8-4
|
pubmed:meshHeading |
pubmed-meshheading:8459267-Adult,
pubmed-meshheading:8459267-Aged,
pubmed-meshheading:8459267-Cisplatin,
pubmed-meshheading:8459267-Dexamethasone,
pubmed-meshheading:8459267-Drug Evaluation,
pubmed-meshheading:8459267-Female,
pubmed-meshheading:8459267-Humans,
pubmed-meshheading:8459267-Male,
pubmed-meshheading:8459267-Middle Aged,
pubmed-meshheading:8459267-Nausea,
pubmed-meshheading:8459267-Ondansetron,
pubmed-meshheading:8459267-Vomiting
|
pubmed:year |
1993
|
pubmed:articleTitle |
Ondansetron plus dexamethasone in the control of high dose cisplatin-induced emesis.
|
pubmed:affiliation |
Oncology Clinic, Università di Messina, Italy.
|
pubmed:publicationType |
Journal Article
|